CRO/Sponsor

Webinar Date/Time: Tuesday, September 26th, 2023 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST

First-of-its-kind consortium dedicated to accelerating new medicines development through optimizing patient advocacy group—industry collaboration.

The adaptability and innovative capacity of CROs highlighted in EUCROF survey.

Use the five stages of change model to solve this common paradigm in clinical trials.

Tufts CSDD study breaks down state of the talent pipeline from lens of senior leaders.

Webinar Date/Time: Wednesday, March 29th, 2023 at 11am | 8am PDT | 4pm BST | 5pm CEST

Sunny Kumar, MD, partner at GSR Ventures speaks about venture capital in clinical research at the SCOPE 2023 conference in Orlando, FL.

Murray L. Aitken, SVP of IQVIA speaks about the concerns of smaller biopharma companies getting into clinical trials at the SCOPE 2023 conference in Orlando, FL.

Researchers face various challenges that cause their clinical trials to fail to meet enrollment timelines, among other issues.

Webinar Date/Time: Mon, Feb 13, 2023 10:00 AM EST

Webinar Date/Time: Wednesday, December 7th, 2022 at 11am EST | 8am PST | 4pm GMT | 5pm CET

Differentiating FSO and FSP approaches can better align definitions of models for CROs and sponsors.

Danielle Mitchell, Founder of Black Women in Clinical Research, discusses how her foundation bridges the gap between minority professionals and clinical trials.

Aggressive focus by DOJ has put increased burden on stakeholders to understand their obligations and exposure.

Work across varying therapeutic areas and new technology among reasons why CROs are qualified to advance model.

Minimizing impacts through focus on employee wellness.

26 interviews conducted by Tufts CSDD found that gender-based microaggressions can negatively impact collaboration and affect retention of women employees.

Survey taken by CROs and pharma/biotech companies seeks answers in maximizing partnership.

How Clinical Research Malaysia sped up CTA turnaround using a web-based system.

In this Q&A, ACT catches up with Brian Ford, director, functional service partnership solutions, PPD Clinical Research Services, Thermo Fisher Scientific, to answer some frequently asked questions about how ILs contribute to the successful use of FSP models.

Patients reap benefits of strong collaboration in executing DCTs.

Porter discusses regulatory compliance, ATMP sponsors, and Philadelphia’s Cellicon Valley.

How pharmaceutical start-ups can mitigate risk and avoid costly hiring mistakes.

Industry provides endless methods in crafting solutions for patients.

Finalizing protocols, aligning teams, and staying engaged headline best practices.

Reminding clinical research stakeholders to reprioritize routine assessment of patient satisfaction as a primary outcome measure in patient-centric activities.

How CROs have adapted to recent challenges—and how they’ll continue to evolve in the future.

Brief history lesson sets stage for current state of CROs.

Industry must take advantage of "lessons learned."